[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 71, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph Michael Redmond", "age": 62, "title": "President & Interim Principal Executive Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 9611}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 51, "title": "CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 314896, "exercisedValue": 0, "unexercisedValue": 4554}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer & Member of Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.14, "open": 1.15, "dayLow": 1.0904, "dayHigh": 1.16, "regularMarketPreviousClose": 1.14, "regularMarketOpen": 1.15, "regularMarketDayLow": 1.0904, "regularMarketDayHigh": 1.16, "beta": 0.497, "forwardPE": -0.10324074, "volume": 221323, "regularMarketVolume": 221323, "averageVolume": 130325, "averageVolume10days": 162140, "averageDailyVolume10Day": 162140, "bid": 1.12, "ask": 1.16, "bidSize": 800, "askSize": 1100, "marketCap": 6222469, "fiftyTwoWeekLow": 0.97, "fiftyTwoWeekHigh": 7.74, "priceToSalesTrailing12Months": 301.63696, "fiftyDayAverage": 1.5776, "twoHundredDayAverage": 2.82705, "currency": "USD", "enterpriseValue": 4643546, "floatShares": 4055475, "sharesOutstanding": 5580690, "sharesShort": 57047, "sharesShortPriorMonth": 58982, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.010199999, "heldPercentInsiders": 0.23231001, "heldPercentInstitutions": 0.10158, "shortRatio": 1.05, "shortPercentOfFloat": 0.0113, "bookValue": 0.23, "priceToBook": 4.847826, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -20261732, "trailingEps": -8.47, "forwardEps": -10.8, "lastSplitFactor": "1:10", "lastSplitDate": 1516579200, "enterpriseToRevenue": 225.098, "enterpriseToEbitda": -0.227, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "OGEN", "underlyingSymbol": "OGEN", "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "firstTradeDateEpochUtc": 1077719400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "747ffae6-a5e0-3f81-bef4-ef8201719134", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.115, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 2071989, "totalCashPerShare": 0.462, "ebitda": -20437256, "totalDebt": 126840, "quickRatio": 2.28, "currentRatio": 2.689, "totalRevenue": 20629, "debtToEquity": 4.832, "revenuePerShare": 0.008, "returnOnAssets": -1.6328, "returnOnEquity": -3.14875, "freeCashflow": -10301939, "operatingCashflow": -8246434, "operatingMargins": -991.8169, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-14"}]